Engelsk titel: A paradigm shift for prostate cancer diagnostics
Läs online
Författare:
Bratt, Ola
Email: ola.bratt@vgregion.se
Språk: Swe
Antal referenser: 10
Dokumenttyp:
Artikel
UI-nummer: 19010066
Sammanfattning
The current praxis of diagnosing prostate cancer, with systematic prostate biopsies in men with raised serum prostate-specific antigen (PSA) levels, leads to considerable over-diagnosis and over-treatment of indolent cancer. Recent research has opened up for a paradigm shift to risk stratified, sequential and targeted prostate cancer diagnostics, which will reduce over-diagnosis. Sweden now moves towards organised PSA testing for those men who, after proper counselling, wish to be tested. Organised PSA testing will provide the necessary infrastructure for research on the new paradigm for prostate cancer diagnostics and the later implementation of population based prostate cancer screening.